Abstract

BackgroundSepsis and septic shock remain drivers for mortality in critically ill patients. The heterogeneity of the syndrome hinders the generation of reproducible numbers on mortality risks. Consequently, mortality rates range from 15 to 56%. We aimed to update and extend the existing knowledge from meta-analyses and estimate 30- and 90-day mortality rates for sepsis and septic shock separately, stratify rates by region and study type and assess mortality rates across different sequential organ failure assessment (SOFA) scores.MethodsWe performed a systematic review of articles published in PubMed or in the Cochrane Database, between 2009 and 2019 in English language including interventional and observational studies. A meta-analysis of pooled 28/30- and 90-day mortality rated separately for sepsis and septic shock was done using a random-effects model. Time trends were assessed via Joinpoint methodology and for the assessment of mortality rate over different SOFA scores, and linear regression was applied.ResultsFour thousand five hundred records were identified. After title/abstract screening, 783 articles were assessed in full text for eligibility. Of those, 170 studies were included. Average 30-day septic shock mortality was 34.7% (95% CI 32.6–36.9%), and 90-day septic shock mortality was 38.5% (95% CI 35.4–41.5%). Average 30-day sepsis mortality was 24.4% (95% CI 21.5–27.2%), and 90-day sepsis mortality was 32.2% (95% CI 27.0–37.5%). Estimated mortality rates from RCTs were below prospective and retrospective cohort studies. Rates varied between regions, with 30-day septic shock mortality being 33.7% (95% CI 31.5–35.9) in North America, 32.5% (95% CI 31.7–33.3) in Europe and 26.4% (95% CI 18.1–34.6) in Australia. A statistically significant decrease of 30-day septic shock mortality rate was found between 2009 and 2011, but not after 2011. Per 1-point increase of the average SOFA score, average mortality increased by 1.8–3.3%.ConclusionTrends of lower sepsis and continuous septic shock mortality rates over time and regional disparities indicate a remaining unmet need for improving sepsis management. Further research is needed to investigate how trends in the burden of disease influence mortality rates in sepsis and septic shock at 30- and 90-day mortality over time.

Highlights

  • Sepsis and septic shock remain drivers for mortality in critically ill patients

  • Studies were included if they (i) enrolled adult patients with suspected or confirmed sepsis, severe sepsis, or septic shock according to the definition by Bone et al [14] or sepsis in the Sepsis-3 definition [15]; (ii) reported overall 30- ± 2 days) or 90-day mortality; and (iii) were published between 2009 and 2019

  • Our results present a comprehensive view of the mortality in sepsis and septic shock, showing that average 30-day mortality in septic shock was 34.7% and 90-day mortality in septic shock was 38.5%

Read more

Summary

Introduction

Sepsis and septic shock remain drivers for mortality in critically ill patients. The heterogeneity of the syndrome hinders the generation of reproducible numbers on mortality risks. The heterogeneity of sepsis and septic shock hinders the generation of reproducible data on mortality risks, with ranges between 15 and 56% reported [1, 3,4,5,6]. There is dissent regarding trends in mortality over time, and while most studies have reported a decline, the annual decrease has been estimated in the range of 0.42 to 3.3% [1, 7,8,9]. These variations may in part be explained by variations in severity, type of study, geographical region and improvements in the standard of care. One significant argument to stop the bundle, for the US, was justified by potential differences between the US and resource-limited countries, albeit that systematic data for regional differences are lacking

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call